February 25, 2026

Sleep Apnea’s Billion-Dollar Toll

New analysis links untreated OSA to major productivity losses in working-age adults in the US and UK

Conexiant

February 17, 2026

FDA Broadens Pitolisant Label

The US Food and Drug Administration approves pitolisant (WAKIX) tablets for the treatment of cataplexy in pediatric patients aged 6 years and older with narcolepsy.

Conexiant

February 17, 2026

CKD Markers Linked to Cognitive Risk

In adults with chronic kidney disease, higher proteinuria and lower estimated glomerular filtration rate are associated with increased risk of incident cognitive impairment.

Conexiant

February 17, 2026

VA DOD Updates Asthma Framework

The 2025 US Department of Veterans Affairs and US Department of Defense asthma guideline introduces 21 evidence-based recommendations for primary care, redefining stepwise treatment, comorbidity management, and reliever strategy.

Conexiant

February 12, 2026

FDA Approves HRT Label Changes

The agency cited updated evidence in revising hormone therapy safety language.

Conexiant

February 12, 2026

Curbing Drug-Related Halitosis for Closer Moments

Individuals who have drug-related halitosis may need to take additional steps to prioritize oral health before intimate encounters.

Conexiant

February 11, 2026

Anxiety Linked to Gut Disease Trajectories

Longitudinal electronic health record data are used to examine temporal relationships between psychiatric and gastrointestinal diagnoses.

Conexiant

February 10, 2026

Sleep Disorders Linked to Higher RA Prevalence

Results suggest sleep-related inflammation may play a role in RA, though causality remains unclear.

Conexiant

February 06, 2026

Tracking Opioid Refills After Surgery

Researchers evaluated perioperative and postdischarge factors associated with opioid refill prescriptions during the first 90 days after inpatient otolaryngology–head and neck surgery.

Conexiant